Gadd45 in the liver: Signal transduction and transcriptional mechanisms

Advances in Experimental Medicine and Biology

Volumn 793, Issue , 2013, Pages 69-80

  Tian, Jianmin ^a   Locker, Joseph ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONSTITUTIVE ANDROSTANE RECEPTOR; ESTROGEN RECEPTOR ALPHA; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45ALPHA; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45GAMMA; JANUS KINASE 2; LYMPHOTOXIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; RETINOIC ACID RECEPTOR ALPHA; RETINOID X RECEPTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL DAMAGE; CELL PROLIFERATION; ENZYME ACTIVATION; ENZYME INHIBITION; LIVER CELL; LIVER CELL CARCINOMA; LIVER HYPERPLASIA; LIVER PROTECTION; LIVER REGENERATION; NONHUMAN; ORGAN GROWTH; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 84934439375     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-8289-5_5     Document Type: Article

References (60)

1. Amente S, Zhang J, Lavadera ML, Lania L, Avvedimento EV, Majello B (2011) Myc and PI3K/ AKT signaling cooperatively repress FOXO3a-dependent PUMA and GADD45a gene expression. Nucleic Acids Res 39:9498-9507.
2. Baskin-Bey ES, Huang W, Ishimura N, Isomoto H, Bronk SF, Braley K et al (2006) Constitutive androstane receptor (CAR) ligand, TCPOBOP, attenuates Fas-induced murine liver injury by altering Bcl-2 proteins. Hepatology 44:252-262.
3. Baskin-Bey ES, Anan A, Isomoto H, Bronk SF, Gores GJ (2007) Constitutive androstane receptor agonist, TCPOBOP, attenuates steatohepatitis in the methionine choline-deficient diet-fed mouse. World J Gastroenterol 13:5635-5641.
4. Bortoff KD, Keeton AB, Franklin JL, Messina JL (2010) Anti-inflammatory action of insulin via induction of Gadd45-beta transcription by the mTOR signaling pathway. Hepat Med 2001:79-85.
5. Campanero MR, Herrero A, Calvo V (2008) The histone deacetylase inhibitor trichostatin A induces GADD45 gamma expression via Oct and NF-Y binding sites. Oncogene 27:1263-1272.
6. Columbano A, Shinozuka H (1996) Liver regeneration versus direct hyperplasia. FASEB J 10:1118-1128.
7. Columbano A, Ledda-Columbano GM, Pibiri M, Cossu C, Menegazzi M, Moore DD et al (2005) Gadd45beta is induced through a CAR-dependent, TNF-independent pathway in murine liver hyperplasia. Hepatology 42:1118-1126.
8. De Smaele E, Zazzeroni F, Papa S, Nguyen DU, Jin R, Jones J et al (2001) Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. Nature 414:308-313.
9. Fallsehr C, Zapletal C, Kremer M, Demir R, von Knebel DM, Klar E (2005) Identification of differentially expressed genes after partial rat liver ischemia/reperfusion by suppression subtractive hybridization. World J Gastroenterol 11:1303-1316.
10. Fletcher N, Wahlstrom D, Lundberg R, Nilsson CB, Nilsson KC, Stockling K et al (2005) 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the mRNA expression of critical genes associated with cholesterol metabolism, bile acid biosynthesis, and bile transport in rat liver: a microarray study. Toxicol Appl Pharmacol 207:1-24.
11. Flores AM, Li L, Aneskievich BJ (2004) Isolation and functional analysis of a keratinocytederived, ligand-regulated nuclear receptor comodulator. J Invest Dermatol 123:1092-1101.
12. Frau M, Simile MM, Tomasi ML, Demartis MI, Daino L, Seddaiu MA et al (2012) An expression signature of phenotypic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis. Cell Oncol (Dordr) 35:163-173.
13. Heery DM, Kalkhoven E, Hoare S, Parker MG (1997) A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387:733-736.
14. Higgs MR, Lerat H, Pawlotsky JM (2010) Downregulation of Gadd45beta expression by hepatitis C virus leads to defective cell cycle arrest. Cancer Res 70:4901-4911.
15. Hollander MC, Kovalsky O, Salvador JM, Kim KE, Patterson AD, Haines DC et al (2001) Dimethylbenzanthracene carcinogenesis in Gadd45a-null mice is associated with decreased DNA repair and increased mutation frequency. Cancer Res 61:2487-2491.
16. Huang H, Wang H, Sinz M, Zoeckler M, Staudinger J, Redinbo MR et al (2007) Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazole. Oncogene 26:258-268.
17. Jee S, Hwang D, Seo S, Kim Y, Kim C, Kim B et al (2007) Microarray analysis of insulin-regulated gene expression in the liver: the use of transgenic mice co-expressing insulin-siRNA and human IDE as an animal model. Int J Mol Med 20:829-835.
18. Jin S, Zhao H, Fan F, Blanck P, Fan W, Colchagie AB et al (2000) BRCA1 activation of the GADD45 promoter. Oncogene 19:4050-4057.
19. Jin R, De Smaele E, Zazzeroni F, Nguyen DU, Papa S, Jones J et al (2002) Regulation of the gadd45ß promoter by NF-?B. DNA Cell Biol 21:491-503.
20. Kastan MB, Bartek J (2004) Cell-cycle checkpoints and cancer. Nature 432:316-323.
21. Kodama S, Negishi M (2011) Pregnane X receptor PXR activates the GADD45beta gene, eliciting the p38 MAPK signal and cell migration. J Biol Chem 286:3570-3578.
22. Ledda-Columbano GM, Pibiri M, Loi R, Perra A, Shinozuka H, Columbano A (2000) Early increase in cyclin-D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1, 4-Bis[2-(3, 5-Dichloropyridyloxy)] benzene. Am J Pathol 156:91-97.
23. Liebermann DA, Hoffman B (2008) Gadd45 in stress signaling. J Mol Signal 3:15.
24. Locker J, Tian J, Carver R, Concas D, Cossu C, Ledda-Columbano GM et al (2003) A common set of immediate-early response genes in liver regeneration and hyperplasia. Hepatology 38:314-325.
25. Luebke-Wheeler J, Zhang K, Battle M, Si-Tayeb K, Garrison W, Chhinder S et al (2008) Hepatocyte nuclear factor 4alpha is implicated in endoplasmic reticulum stress-induced acute phase response by regulating expression of cyclic adenosine monophosphate responsive element binding protein H. Hepatology 48:1242-1250.
26. Maekawa T, Sano Y, Shinagawa T, Rahman Z, Sakuma T, Nomura S et al (2008) ATF-2 controls transcription of Maspin and GADD45 alpha genes independently from p53 to suppress mammary tumors. Oncogene 27:1045-1054.
27. Major MB, Jones DA (2004) Identification of a gadd45beta 3' enhancer that mediates SMAD3-and SMAD4-dependent transcriptional induction by transforming growth factor beta. J Biol Chem 279:5278-5287.
28. Michalopoulos GK (2007) Liver regeneration. J Cell Physiol 213:286-300.
29. Notas G, Alexaki VI, Kampa M, Pelekanou V, Charalampopoulos I, Sabour-Alaoui S et al (2012) APRIL binding to BCMA activates a JNK2-FOXO3-GADD45 pathway and induces a G2/M cell growth arrest in liver cells. J Immunol 189:4748-4758.
30. Ohmura T, Ledda-Columbano GM, Piga R, Columbano A, Glemba J, Katyal SL et al (1996) Hepatocyte proliferation induced by a single dose of a peroxisome proliferator. Am J Pathol 148:815-824.
31. Ou DL, Shen YC, Yu SL, Chen KF, Yeh PY, Fan HH et al (2010) Induction of DNA damageinducible gene GADD45beta contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells. Cancer Res 70:9309-9318.
32. Papa S, Zazzeroni F, Bubici C, Jayawardena S, Alvarez K, Matsuda S et al (2004) Gadd45 beta mediates the NF-kappa B suppression of JNK signalling by targeting MKK7/JNKK2. Nat Cell Biol 6:146-153.
33. Papa S, Monti SM, Vitale RM, Bubici C, Jayawardena S, Alvarez K et al (2007) Insights into the structural basis of the GADD45beta-mediated inactivation of the JNK kinase, MKK7/JNKK2. J Biol Chem 282:19029-19041.
34. Papa S, Zazzeroni F, Fu YX, Bubici C, Alvarez K, Dean K et al (2008) Gadd45beta promotes hepatocyte survival during liver regeneration in mice by modulating JNK signaling. J Clin Invest 118:1911-1923.
35. Papa S, Bubici C, Zazzeroni F, Franzoso G (2009) Mechanisms of liver disease: cross-talk between the NF-kappaB and JNK pathways. Biol Chem 390:965-976.
36. Pike AC (2006) Lessons learnt from structural studies of the oestrogen receptor. Best Pract Res Clin Endocrinol Metab 20:1-14.
37. Qiu W, David D, Zhou B, Chu PG, Zhang B, Wu M et al (2003) Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma. Am J Pathol 162:1961-1974.
38. Qiu W, Zhou B, Zou H, Liu X, Chu PG, Lopez R et al (2004) Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma. Am J Pathol 165:1689-1699.
39. Sabapathy K, Wagner EF (2004) JNK2: a negative regulator of cellular proliferation. Cell Cycle 3:1520-1523.
40. Sabapathy K, Hochedlinger K, Nam SY, Bauer A, Karin M, Wagner EF (2004) Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. Mol Cell 15:713-725.
41. Seewoo V, Yang W, Du H, Wang J, Lin A, Shen B et al (2012) The different induction mechanisms of growth arrest DNA damage inducible gene 45 beta in human hepatoma cell lines. Chemotherapy 58:165-174.
42. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA et al (1998) The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95:927-937.
43. Shimizu YI, Morita M, Ohmi A, Aoyagi S, Ebihara H, Tonaki D et al (2009) Fasting induced upregulation of activating transcription factor 5 in mouse liver. Life Sci 84:894-902.
44. Su AI, Guidotti LG, Pezacki JP, Chisari FV, Schultz PG (2002) Gene expression during the priming phase of liver regeneration after partial hepatectomy in mice. Proc Natl Acad Sci USA 99:11181-11186.
45. Suenaga K, Takasawa H, Watanabe T, Wako Y, Suzuki T, Hamada S et al (2013) Differential gene expression profiling between genotoxic and non-genotoxic hepatocarcinogens in young rat liver determined by quantitative real-time PCR and principal component analysis. Mutat Res 751:73-83.
46. Sytnikova YA, Kubarenko AV, Schafer A, Weber AN, Niehrs C (2011) Gadd45a is an RNA binding protein and is localized in nuclear speckles. PLoS One 6:e14500.
47. Tian J, Huang H, Hoffman B, Liebermann DA, Ledda-Columbano GM, Columbano A et al (2011) Gadd45beta is an inducible coactivator of transcription that facilitates rapid liver growth in mice. J Clin Invest 121:4491-4502.
48. Torchia J, Rose DW, Inostroza J, Kamei Y, Westin S, Glass CK et al (1997) The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387:677-684.
49. Tornatore L, Marasco D, Dathan N, Vitale RM, Benedetti E, Papa S et al (2008) Gadd45 beta forms a homodimeric complex that binds tightly to MKK7. J Mol Biol 378:97-111.
50. Vairapandi M, Azam N, Balliet AG, Hoffman B, Liebermann DA (2000) Characterization of MyD118, Gadd45, and proliferating cell nuclear antigen (PCNA) interacting domains. PCNA impedes MyD118 AND Gadd45-mediated negative growth control. J Biol Chem 275: 16810-16819.
51. Yamada Y, Webber EM, Kirillova I, Peschon JJ, Fausto N (1998) Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor. Hepatology 28:959-970.
52. Yamamoto Y, Moore R, Flavell RA, Lu B, Negishi M (2010) Nuclear receptor CAR represses TNFalpha-induced cell death by interacting with the anti-apoptotic GADD45B. PLoS One 5:e10121.
53. Yan SJ, Lee YF, Ting HJ, Liu NC, Liu S, Lin SJ et al (2012) Deficiency in TR4 nuclear receptor abrogates Gadd45a expression and increases cytotoxicity induced by ionizing radiation. Cell Mol Biol Lett 17:309-322.
54. Yasumo H, Masuda N, Furusawa T, Tsukamoto T, Sadano H, Osumi T (2000) Nuclear receptor binding factor-2 (NRBF-2), a possible gene activator protein interacting with nuclear hormone receptors. Biochim Biophys Acta 1490:189-197.
55. Yi Y-W, Kim D, Jung N, Hong S-S, Lee H-S, Bae I (2000) Gadd45 family proteins are coactivators of nuclear hormone receptors. Biochem Biophys Res Commun 272:193-198.
56. Yoo J, Ghiassi M, Jirmanova L, Balliet AG, Hoffman B, Fornace AJ Jr et al (2003) Transforming growth factor-beta-induced apoptosis is mediated by Smad-dependent expression of GADD45b through p38 activation. J Biol Chem 278:43001-43007.
57. Zhan Q, Chen IT, Antinore MJ, Fornace AJ Jr (1998) Tumor suppressor p53 can participate in transcriptional induction of the GADD45 promoter in the absence of direct DNA binding. Mol Cell Biol 18:2768-2778.
58. Zhang C, Wang J, Lu G, Li J, Lu X, Mantion G et al (2012) Hepatocyte proliferation/growth arrest balance in the liver of mice during E. multilocularis infection: a coordinated 3-stage course. PLoS One 7:e30127.
59. Zhao H, Jin S, Antinore MJ, Lung FD, Fan F, Blanck P et al (2000) The central region of Gadd45 is required for its interaction with p21/WAF1. Exp Cell Res 258:92-100.
60. Zhou D, Palam LR, Jiang L, Narasimhan J, Staschke KA, Wek RC (2008) Phosphorylation of eIF2 directs ATF5 translational control in response to diverse stress conditions. J Biol Chem 283:7064-7073.